Mehdi Yazdi the Art of API Method Development
Posted: October 12, 2018
Dr. Mehdi Yazdi Director of Analytical Services talks about the art of API method development at PCI Synthesis.
Related posts:
So How Much Does a Molecule Actually Cost to Manufacture?
The Growing Role of Polymer Synthesis Driven by Modern Advances in Drug Delivery
Why Cost-Overruns May Mean Extra Budget, but Little Profit for Anyone
How Lyophilization Speeds Development of APIs and Polymers
Growth of targeted therapies gives rise to need for flexible manufacturing of smaller API quantities
About the Author
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...
